• Explore /
  • Poster
  • / Real world outcome of patients with multiple myeloma who received bispecific antibodies after CAR-T therapy.

Real world outcome of patients with multiple myeloma who received bispecific antibodies after CAR-T therapy.

Abstract Poster

Authors

Radhika Bansal

Radhika Bansal

Division of Hematology, Mayo Clinic, Rochester, MN

Radhika Bansal , Andre De Menezes Silva Corraes , Larissa Brunaldi , Tyler B Sandahl , Matthew J. Rees , Suzanne R. Hayman , Moritz Binder , Nadine Abdallah , David Dingli , Joselle Cook , Morie A. Gertz , Prashant Kapoor , Taxiarchis Kourelis , Rahma M. Warsame , Shaji Kumar , Yi Lin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Plasma Cell Dyscrasia

Track

Hematologic Malignancies

Sub Track

Cell Therapy, Bispecific Antibodies, and Autologous Stem Cell Transplantation for Plasma Cell Disorders

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 7520)

DOI

10.1200/JCO.2024.42.16_suppl.7520

Abstract #

7520

Poster Bd #

157

Abstract Disclosures

Similar Posters

First Author: Jian-Qing Mi

First Author: Karnav Modi

First Author: Niels W.C.J. van de Donk

First Author: Suzette Girgis